RX Bandz, Inc.
Denville, NJ
- UEI
- DXRED7S6FVE9
- CAGE
- 7N2K8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 12 Luger Rd, Denville, NJ 07834, USA
- Website
- rxbandz.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $5,769,706 |
| FY2025 | $2,650,000 |
| FY2024 | $3,233,081 |
| FY2023 | $4,374,411 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Air Force | $5,769,706 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
RX Bandz, Inc. is a small disadvantaged, woman-owned business headquartered in Austin, Texas, specializing in medical equipment manufacturing with a focus on innovative auto-injector and drug delivery technologies. Registered in SAM.gov since 2016, the company has established itself as a critical technology partner for the U.S. Department of Defense, particularly in developing advanced medical solutions for military personnel. The company is structured as a for-profit organization and has demonstrated expertise in creating specialized medical delivery systems designed to address emergency medical needs in combat and field environments.
The company has primarily worked with the Air Force Research Laboratory and the Department of Defense on Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) contracts, consistently receiving total small business set-aside awards. RX Bandz has developed a range of tactical injector kits and auto-injector systems for delivering critical medications including hydromorphone, ketamine, tranexamic acid (TXA), epinephrine, and other emergency treatments. Their contract awards, ranging from $49,434 to $12,334,570, focus on innovative medical technologies aimed at improving battlefield medical care, such as life-saving mini auto-injectors, medications for pain management, hemorrhage control, and emergency treatment of critically injured service members. The contracts consistently demonstrate the company's commitment to developing cutting-edge medical technologies that can be rapidly deployed to support U.S. military medical readiness and personnel survival.
SBA capabilities narrative
Medical Device Development, Drug Delivery, Auto-Injectors
Quick answers
Is RX Bandz, Inc. registered in SAM.gov?
Yes. RX Bandz, Inc.'s SAM.gov registration is active through October 1, 2027.
How much has RX Bandz, Inc. received in federal contracts?
Federal contracts obligated $2,650,000 to RX Bandz, Inc. in fiscal year 2025 and $16,027,198 in fiscal years 2023 through 2027.
How does RX Bandz, Inc. rank among federal contractors?
RX Bandz, Inc. ranked #4 in PSC AA in FY2025.
What is RX Bandz, Inc.'s most recent federal award?
RX Bandz, Inc.'s most recent federal contract award is Tactical injector kit - hydromorphone (FA238424CB014), from Air Force, on September 30, 2024.
On GovTribe
See RX Bandz, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors